Maria João Saraiva
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Molecular mechanisms in the clearance of protein aggregates in misfolding disorders
Open Date: 2013-07-01
Close Date: 2015-06-30
Grant: Close
Molecular mechanisms in the clearance of protein aggregates in misfolding disorders
Open Date: 2013-07-01
Close Date: 2015-06-01
Grant: Close
Molecular basis of nervous system dysfunction on amyloid neuropathies
Open Date: 2011-01-01
Close Date: 2013-06-30
Grant: Close
Therapies in familial amyloidotic polyneuropathy
Open Date: 2009-01-01
Close Date: 2011-03-01
Grant: Close
Therapies in familial amyloidotic polyneuropathy
Open Date: 2009-01-01
Close Date: 2011-03-31
Articles (16)
Hereditary amyloid transthyretin (ATTRv) amyloidosis is a fatal neurodegenerative disorder, first identified in Portugal. The most common transthyretin (TTR) mutation in ATTRv results from an exchange of a methionine for a valine at position 30 (V30M). ATTRv is characterized by the extracellular deposition of aggregates and fibrils of mutant forms of TTR, particularly in the nerves and ganglia of the peripheral nervous system (PNS). This phenotype is often accompanied by the lack of inflammatory infiltrates, despite the importance of macrophages in removal of TTR deposits in ATTRv patients. The mechanisms underlying this impairment of inflammatory responses in ATTRv patients are poorly understood. Here, we show a significant down-regulation in the expression of several chemokines by bone marrow-derived macrophages (BMDM) generated from V30M TTR mice upon stimulation with toll-like receptor 4 (TLR4) and TLR2 agonists. The phosphorylation of the MAP kinase p38, important for TLR4 and TLR2 signaling pathways, was also down-regulated in V30M macrophages, as compared with wild-type (WT) ones. The present study contributes with new insights to unravel the molecular mechanisms underlying the lack of inflammatory immune responses observed in ATTRv patients and may help in the development of new immune therapeutic strategies for the disease.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (7)
Sonia Batista
-
Carlos B. Duarte
Full Professor
University of Coimbra
Isabel Conceição
Universidade de Aveiro
Maria Almeida
Associate Professor
University of Porto
Ole Suhr
Senior Professor
Umeå Universitet Medicinska fakulteten
Ana Terceiro
Instituto Universitário de Ciências da Saúde
Rui Magalhães
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar
Make your next move.
Prepare your application
Review drafts before you send them.